These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9172239)

  • 21. [Differential diagnosis of peripheral neuropathy].
    Imreová H; Pura M
    Cas Lek Cesk; 2005; 144(9):628-33; discussion 633-5. PubMed ID: 16193943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occupational peripheral neuropathies.
    Lotti M; Becker CE; Aminoff MJ
    West J Med; 1982 Dec; 137(6):493-8. PubMed ID: 6299013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pauci-symptomatic sensory polyneuropathy in Refsum's disease].
    Lévy R; Verny M; Brault JL; Gugenheim M; Maisonobe T; Léger JM
    Rev Neurol (Paris); 1996; 152(6-7):469-72. PubMed ID: 8944245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peripheral neuropathy evaluation in an office-based neurology setting.
    Vavra MW; Rubin DI
    Semin Neurol; 2011 Feb; 31(1):102-14. PubMed ID: 21321837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral nerve diseases: the bare essentials.
    Hughes R
    Pract Neurol; 2008 Dec; 8(6):396-405. PubMed ID: 19015303
    [No Abstract]   [Full Text] [Related]  

  • 26. An approach to the evaluation of peripheral neuropathies.
    Bromberg MB
    Semin Neurol; 2010 Sep; 30(4):350-5. PubMed ID: 20941667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large and small fiber neuropathy in chronic alcohol-dependent subjects.
    Zambelis T; Karandreas N; Tzavellas E; Kokotis P; Liappas J
    J Peripher Nerv Syst; 2005 Dec; 10(4):375-81. PubMed ID: 16279987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of nerve conduction studies in myotonic dystrophy type 1: primary involvement of nerves or incidental coexistence?
    Bae JS; Kim OK; Kim SJ; Kim BJ
    J Clin Neurosci; 2008 Oct; 15(10):1120-4. PubMed ID: 18657426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute polyneuropathy in the critical patient. Description of a clinical case].
    de Pietri P; Foroni C; Malusardi P; Minuto A; Sicignano A; Vesconi S; Vetrò A
    Minerva Anestesiol; 1989 Dec; 55(12):523-5. PubMed ID: 2561522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasculitic neuropathy--electrodiagnostic findings and association with malignancies.
    Zivković SA; Ascherman D; Lacomis D
    Acta Neurol Scand; 2007 Jun; 115(6):432-6. PubMed ID: 17511855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological case definitions of peripheral neuropathy: experience from two neurotoxicity studies.
    Gerr F; Letz R
    Neurotoxicology; 2000 Oct; 21(5):761-8. PubMed ID: 11130280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to the evaluation of small fiber peripheral neuropathy and disorders of orthostatic intolerance.
    Goodman BP
    Semin Neurol; 2007 Sep; 27(4):347-55. PubMed ID: 17701872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of polyneuropathies].
    Crone C; Krarup C
    Ugeskr Laeger; 1998 Nov; 160(45):6503-15. PubMed ID: 9816960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibromyalgia--management of a misunderstood disorder.
    Peterson EL
    J Am Acad Nurse Pract; 2007 Jul; 19(7):341-8. PubMed ID: 17680899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology.
    Goldfarb AR; Latov N; Brannagan TH; Chin RL; de Sousa EA; Sander HW
    Neurol Neurophysiol Neurosci; 2006 Dec; ():7. PubMed ID: 17260084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired demyelinative polyneuropathy: diagnosis and treatment with special reference to immunosuppressive therapy.
    Streib EW; Sun SF
    Nebr Med J; 1984 Mar; 69(3):60-3. PubMed ID: 6325956
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of plasmapheresis in patients with AIDS and peripheral polyneuropathy].
    Lapiński TW; Prokopowicz D
    Pol Merkur Lekarski; 1999 Nov; 7(41):215-7. PubMed ID: 10680453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.